1. Home
  2. PPBT

PPBT

Purple Biotech Ltd.

Logo Purple Biotech Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 11:33am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Founded: 2010 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 11.8M IPO Year: N/A
Target Price: $10.00 AVG Volume (30 days): 116.3K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.90 EPS Growth: N/A
52 Week Low/High: $0.53 - $2.16 Next Earning Date: 05-14-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: